While monocyte and neutrophil numbers may be higher in CKD patients, with higher levels of activation markers (e.g., CD11b), their ability to respond to pathogenic challenges, notably in terms of cytokine production, is reduced (Lim et al., 2007). This evidence concerns the gene ITGAM and chronic kidney disease.